Shaanxi Micot Pharmaceutical Technology Co., Ltd.

This study tested a new drug called MT1013 in 98 adults on hemodialysis who have secondary hyperparathyroidism, a condition where parathyroid hormone levels are too high. The goal was to see if the drug is safe and can lower hormone levels. Participants received either the drug o…

This study tested a new injection called MT1013 in 115 adults with chronic kidney disease who are on dialysis and have secondary hyperparathyroidism (overactive parathyroid glands). The goal was to see if the drug could safely lower high parathyroid hormone levels by at least 30%…